Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 1816 AL 1830

Nutritional status assessment in Alzheimer disease and its influence on disease progression

Izquierdo Delgado E, Gutiérrez Ríos R, Andrés Calvo M, Repiso Gento I, Castrillo Sanz A, Rodríguez Herrero R, Rodríguez Sanz MF, Tola-Arribas MA.

Neurologia (Engl Ed). 2022 Nov-Dec;37(9):735-747. doi: 10.1016/j.nrleng.2019.11.006. Epub 2021 Oct 15.

Personality Associations With Amyloid and Tau: Results From the Baltimore Longitudinal Study of Aging and Meta-analysis

Terracciano A, Bilgel M, Aschwanden D, Luchetti M, Stephan Y, Moghekar AR, Wong DF, Ferrucci L, Sutin AR, Resnick SM.

Biol Psychiatry. 2022 Feb 15;91(4):359-369. doi: 10.1016/j.biopsych.2021.08.021. Epub 2021 Sep 3.

Serum aberrant expression of miR-24-3p and its diagnostic value in Alzheimer's disease

Liu L, Liu L, Lu Y, Zhang T, Zhao W.

Biomark Med. 2021 Nov;15(16):1499-1507. doi: 10.2217/bmm-2021-0098. Epub 2021 Oct 20.

Chinese expert consensus statement for diagnosis and treatment of dementia with Lewy bodies 2020

Ji Y, Li YF, Peng DT, Chen ZC; Chinese Society of Geriatrics of Chinese Medical Association, Chinese Society of Microcirculation Neurodegenerative Diseases Committee.

Chin Med J (Engl). 2021 Oct 20;134(21):2529-2531. doi: 10.1097/CM9.0000000000001754.

d-Amino Acids and pLG72 in Alzheimer's Disease and Schizophrenia

Cheng YJ, Lin CH, Lane HY.

Int J Mol Sci. 2021 Oct 9;22(20):10917. doi: 10.3390/ijms222010917.

Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial

Kehoe PG, Turner N, Howden B, Jarutyte L, Clegg SL, Malone IB, Barnes J, Nielsen C, Sudre CH, Wilson A, Thai NJ, Blair PS, Coulthard E, Lane JA, Passmore P, Taylor J, Mutsaerts HJ, Thomas DL, Fox NC, Wilkinson I, Ben-Shlomo Y; RADAR investigators.

Lancet Neurol. 2021 Nov;20(11):895-906. doi: 10.1016/S1474-4422(21)00263-5.

Neuropsychological, neuropsychiatric, and quality-of-life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study

Boada M, López OL, Olazarán J, Núñez L, Pfeffer M, Puente O, Piñol-Ripoll G, Gámez JE, Anaya F, Kiprov D, Alegret M, Grifols C, Barceló M, Bozzo J, Szczepiorkowski ZM, Páez A; AMBAR Trial Group.

Alzheimers Dement. 2022 Jul;18(7):1314-1324. doi: 10.1002/alz.12477. Epub 2021 Nov 2.

[Disease-modifying treatment approaches for Alzheimer's disease]

Frölich L, Hausner L.

Nervenarzt. 2021 Dec;92(12):1239-1248. doi: 10.1007/s00115-021-01222-w. Epub 2021 Nov 4.

Impact of Alzheimer's Disease in Ocular Motility and Visual Perception: A Narrative Review

Almario G, Piñero DP.

Semin Ophthalmol. 2022 May 19;37(4):436-446. doi: 10.1080/08820538.2021.2002371. Epub 2021 Nov 14.

The probabilistic model of Alzheimer disease: the amyloid hypothesis revised

Frisoni GB, Altomare D, Thal DR, Ribaldi F, van der Kant R, Ossenkoppele R, Blennow K, Cummings J, van Duijn C, Nilsson PM, Dietrich PY, Scheltens P, Dubois B.

Nat Rev Neurosci. 2022 Jan;23(1):53-66. doi: 10.1038/s41583-021-00533-w. Epub 2021 Nov 23.

From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's disease

Brown AJH, Bradley SJ, Marshall FH, Brown GA, Bennett KA, Brown J, Cansfield JE, Cross DM, de Graaf C, Hudson BD, Dwomoh L, Dias JM, Errey JC, Hurrell E, Liptrot J, Mattedi G, Molloy C, Nathan PJ, Okrasa K, Osborne G, Patel JC, Pickworth M, Robertson N, Shahabi S, Bundgaard C, Phillips K, Broad LM, Goonawardena AV, Morairty SR, Browning M, Perini F, Dawson GR, Deakin JFW, Smith RT, Sexton PM, Warneck J, Vinson M, Tasker T, Tehan BG, Teobald B, Christopoulos A, Langmead CJ, Jazayeri A, Cooke RM, Rucktooa P, Congreve MS, Weir M, Tobin AB.

Cell. 2021 Nov 24;184(24):5886-5901.e22. doi: 10.1016/j.cell.2021.11.001.

Integrated Positron Emission Tomography/Magnetic Resonance Imaging in clinical diagnosis of Alzheimer's disease

Gao F.

Eur J Radiol. 2021 Dec;145:110017. doi: 10.1016/j.ejrad.2021.110017. Epub 2021 Nov 3.

Digging Deeper: Advancements in Visualization of Inhibitory Synapses in Neurodegenerative Disorders

Radulović S, Sunkara S, Maurer C, Leitinger G.

Int J Mol Sci. 2021 Nov 18;22(22):12470. doi: 10.3390/ijms222212470.

Nutrients, Cognitive Function, and Brain Aging: What We Have Learned from Dogs

Pan Y.

Med Sci (Basel). 2021 Nov 18;9(4):72. doi: 10.3390/medsci9040072.

The efficacy of psychological interventions for depressed primary caregivers of patients with Alzheimer's disease: A systematic review and meta-analysis

Liu X, Wang Y, Wang S.

J Nurs Scholarsh. 2022 May;54(3):355-366. doi: 10.1111/jnu.12742. Epub 2021 Nov 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias